Koutelou M, Prassopoulos V, Lamprakos L, Zissimopoulos A, Chatzipanagiotou T, Mastorakou A, Doumas A. Position statement on the non-invasive diagnosis of patients with ATTR pardiac amyloidosis, endorsed by the Hellenic Society of Nuclear Cardiology, for the Nuclear Medicine practitioners.
Hell J Nucl Med 2023;
26:166-171. [PMID:
38085831 DOI:
10.1967/s002449912600]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Accepted: 12/04/2023] [Indexed: 12/28/2023]
Abstract
Cardiac amyloidosis is a rare condition characterized by the accumulation of abnormal proteins called amyloids in the heart tissue. These amyloids can disrupt the normal functioning of the heart and lead to a variety of symptoms and complications.
Collapse